Home » Topics » Infection, BioWorld Science

Infection, BioWorld Science
RSS

Famvir safe and effective in HIV-infected patients with shingles

Jan. 30, 1997

Microcide reports new cephalosporin antibiotics

Jan. 30, 1997

Synthelabo investigates oxazolidinones

Jan. 30, 1997

N-oxide antibacterial compounds from Bayer

Jan. 30, 1997

New cephem antibacterial agents from Takeda

Jan. 30, 1997

Schering-Plough claims tetrahydrofuran antifungal agents

Jan. 30, 1997

Voriconazole effective in guinea pig model of A. fumigatus endocarditis

Jan. 28, 1997

Mediolanum prepares novel quinolone antibacterial agents

Jan. 28, 1997

Spotlight on influenza sialidase inhibitors

Jan. 28, 1997

Roche presents new antifungal agents

Jan. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Nov. 8, 2024.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for November 8, 2024.
Sales balloon for GLP-1 drugs from Novo Nordisk, Eli Lilly
BioWorld
Nearly $3.8 billion was earned by Novo Nordisk A/S and Eli Lilly and Co. in the third quarter for their glucagon-like peptide-1 (GLP-1) drugs to treat obesity....
Regulatory actions for Oct. 31, 2024
BioWorld
Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Capsida, Electra,...
Australia reimburses Vazkepa a decade after US approval
BioWorld
For the first time, Australians have access to CSL Inc.’s Vazkepa (icosapent ethyl/Vascepa) for managing cardiovascular disease more than a decade after the drug...

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.